We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“To date, the only randomized controlled trial demonstrating benefit of TEER in FMR remains COAPT, a highly selective study whose findings cannot be indiscriminately generalized to broader clinical practice.”
“Positioning mitral TEER alongside guideline-directed medical therapy as a core treatment option reflects the therapy's proven ability to reduce heart failure hospitalisations and mortality while improving quality of life.”
No takes yet. Share an insight, caveat, or question.
Anker et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: